High throughput screening

Molecular Biomethods Handbook: Second Edition

Volumn , Issue , 2008, Pages 1097-1118

  Janzen, William P ^a  

^a Amphora Discovery Sciences (Retired)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900146432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-375-6_60     Document Type: Chapter

References (128)

1. Pharmaceutical Research and Manufacturers of America (2006) Pharmaceutical industry profile 2004. Washington, DC: PhRMA
2. DiMasi J (2001) New drug development in the United States from 1963 to 1999. Clin Pharmacol Therap 69:286-296
3. DiMasi J, Hansen R, Grabowski H (2003) The price of innovation, estimates of drug development costs. J Health Economics 22:151-185
4. Booth B, Zemmel R (2004) Prospects for productivity. Nat Rev Drug Discovery 3:451-456
5. Hopp, Spearman (1996) Factory physics. Richard D Irwin, Chicago
6. Fox S, Farr-Jones S, Sopchak L, Boggs A, Comley J (2004) High-throughput screening: searching for higher productivity. J Biomol Screen 9:354-358
7. Fleming A (1929) On the antibacterial action of cultures of penicillium, with special reference to their use in the isolation of B Influenza. Br J Exp Med 10:226-236
8. Chain EB, Florey HW, Gardner AD, Heatley NG, Jennings MA, Orr-Ewing J, Sanders AG (1940) Penicillin as a chemotherapeutic agent. Lancet 2:226-228
9. Sneader W (1985) Drug discovery: the evolution of modern medicines. John Wiley, NY
10. Smith C (1992) The process of new drug discovery and development. CRC, Boca Raton, FL
11. Watson JD, Crick FHC (1953) Mol Structure Nucleic Acids. Nature 171:737-738
12. McCullough JM (1976) Genetic engineering, human genetics, and cell biology: U.S. Govt. Printing Office, Washington, DC
13. Geysen HM, Meleon RH, Barteling SJ (1984) Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci 81:3998-4002
14. Houghton RA (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-Antibody interactions at the level of individual acids. Proc Natl Acad Sci 82:5131-5135
15. Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discovery 5:785-799
16. Hertzberg R (2002) Design and implementation of high throughput screening. In: Janzen W (ed)) High throughput screening methods and protocols. Humana, Totowa, NJ, pp 1-29
17. Imming P, Sinning C, Meyer A (2006) Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discovery 5:821-834
18. Johnston P (2002) Cellular assays in HTS. In: Janzen W (ed)) High throughput screening methods and protocols Humana, Totowa, NJ, pp 107-116
19. Coecke S, Eskes, C, Gartion J, van Vliet E, Kinsner A, Bogni A, Raimondo L, Parissis N, Langezaal I (2002) Metabolism and neurotoxicity: the significance of genetically engineered cell lines and new three-dimensional cell cultures ATLA 30, Suppl 2:115-118
20. Darrow A, Conway K, Vaidya A, Rosenthal D, Wildey M, Minor L, Itkin Z, Kong Y, Piesvaux J, Qi J, Mercken M, Andrade-Gordon P, Plata-Salamn C, Ilyin S (2003) Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening. J Biomol Screening 8:65-71
21. Xin H, Bernal A, Amato A, Pinhasov A, Kauffman J, Brenneman D, Derian C, Andrade-Gordon P, Plata-Salamn C, Ilyin S (2004) High-Throughput siRNAbased functional target validation. J Biomol Screening 9:286-293
22. Haberman A (2005) Targets and druggablity for small and large molecule drugs. Genetic Engineering News 25:36
23. Bleicher K, Bohm HJ, Muller K, Allanine A (2003) Strategies to move beyond target validation. Nat Rev Drug Discovery 3:369-278
24. Collins I, Workman P (2006) New approaches to molecular cancer therapeutics. Nat Chem Biol 2:689-700
25. Comley J, Reeves T, Robinson P (1998) A 1536 Colorimetric SPAP reporter assay: comparison with 96- and 384-well formats. J Biomol Screening 3:217-225
26. Fox S, Farr-Jones S, Sopchak L, Boggs A, Comley J (2004) High-throughput screening: searching for higher productivity. J Biomol Screening 9:354-358
27. Oldenburg K, Zhang JH, Chen T, Maffia A, Blom K, Combs A, Chung T (1998) Assay miniaturization for ultra-high throughput screening of combinatorial and discrete compound libraries: a 9600-well (0.2 microliter) assay system. J Biomol Screening 3:55-62
28. Berg M, Undisz K, Thiericke R, Zimmermann P, Moore T, Posten C (2001) Evaluation of liquid handling conditions in microplates. J Biomol Screening 2:47-56
29. Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discovery 1:198-210
30. Kulanthaivel P, Hallock Y, Boros C, Hamilton S, Janzen W, Ballas L, Loomis C, Jiang J (1993) Balanol: a novel and potent inhibitor of protein kinase C from the fungus Verticillium balanoides. JACS 115:6452-6453
31. Udenfriend S, Gerber L, Nelson N (1987) Scintillation proximity assay: a sensitive and continuous isotopic method for monitoring ligand/receptor and antigen/ antibody interactions. Anal Biochem 161:494-500
32. Bosworth N, Towers P (1989) Scintillation proximity assay. Nature 341:16
33. Carpenter J, Laethem C, Hubbard F, Eckols T, Baez M, McClure D, Nelson D, Johnston P (2002) Configuring radioligand receptor binding assays for hts using scintillation proximity assay technology: In: Janzen W (ed)) High throughput screening methods and protocols. Humana, Totowa, NJ. pp 31-49
34. Cook N (1996) Scintillation proximity assay - a versatile high throughput screening technology. Drug Discovery Today 1:287-294
35. van der Hee R, Deurholt T, Gerhardt C, de Groene E (2005) Comparison of 3 AT1 receptor binding assays: filtration assay, ScreenReady Target, and WGA Flashplate. J Biomol Screening 10:118-126
36. Fox S (1996) Amersham offers Cytostar-T for cell based assay techniques. Gen Eng News 16:10-11
37. Perrin F (1926) Polarization de la lumiere de fluorescence. Vie moyenne de molecules dans letat excite. J Phys Radium 7:390
38. Weber G (1953) Rotational Brownian motion and polarization of the fluorescence of solutions. Adv Protein Chem 8:415
39. Jolley M (1981) Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human-plasma. J Anal Toxicol 5:236-240
40. Jolley M (1996) Fluorescence polarization assays for the detection of proteases and their inhibitors. J Biomolr Screening 1:33-38
41. Banks P, Gosselin M, Prystay L (2000) fluorescence polarization assays for high throughput screening of g protein-coupled receptors. J Biomol Screening 5:159-167
42. Gaudet E, Huang K, Zhang Y, Huang W, Mark D, Sportsman R (2003) A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J Biomol Screening 8:164-175
43. Owicki J (2000) Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screening 5:297-306
44. Banks P, Harvey M (2002) Considerations for using fluorescence polarization in the screening of G protein-coupled receptors. J Biomol Screening 7:111-117
45. Selvin P (1995) Fluorescence resonance energy transfer. Methods Enzymol 246:300-334
46. Wu P, Brand L (1994) Resonance energy transfer: methods and applications. Anal Biochem 218:1-13
47. Preaudat M, Ouled-Diaf J, Alpha-Bazin B, Mathis G, Mitsugi T, Aono Y, Takahashi K, Takemot H (2002) A homogeneous caspase-3 activity assay using HTRF(R) technology. J Biomol Screening 7:267-274
48. Pope A (1999) Introduction LANCETM vs. HTRF(R) technologies (or vice versa). J Biomol Screening 4:301, 302
49. Mathis G (1999) HTRF(R) technology. J Biomol Screening 4:309-313
50. Yan Y, Boldt-Houle D, Tillotson B, Gee M, DEon B, Chang X, Olesen C, Palmer M (2002) J cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using {beta}-galactosidase enzyme complementation technology. J Biomol Screening 7:451-459
51. Beske O, Guo J, Li J, Bassoni D, Bland K, Marciniak H, Zarowitz M, Temov V, Ravkin I, Goldbard S (2004) A novel encoded particle technology that enables simultaneous interrogation of multiple cell types. J Biomol Screening 9:173-185
52. Ghosh R, DeBiasio R, Hudson C, Ramer E, Cowan C, Oakley R (2005) Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor(R)technology. J Biomol Screening 10:476-484
53. Miraglia S, Swartzman E, Mellentin-Michelotti J, Evangelista L, Smith C, Gunawan I, Lohman K, Goldberg E, Manian B, Yuan P (1999) Homogeneous cell- and bead-based assays for high throughput screening using fluorometric microvolume assay technology. J Biomol Screening 4:193-204
54. Davis G, Downs T, Farmer J, Pierson R, Roesgen J, Cabrera E, Nelson S (2002) Comparison of high throughput screening technologies for luminescence cellbased reporter screens. J Biomol Screening 7:67-77
55. Schroeder K, Neagle B (1996) FLIPR: a new instrument for accurate, high throughput optical screening. J Biomol Screening 3:75-80
56. Baxter D, Kirk M, Garcia A, Raimondi A, Holmqvist M, Flint K, Bojanio D, Distefano P, Curtis R, Xie Y (2002) A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J Biomol Screening 2:79-85
57. Brini M, Marsault R, Bastianutto C, Alvarez J, Pozzan T, Rizzuto R (1995) Transfected aqueorin in the measurement of cytosolic Ca2+ concentration (Ca2+C): a critical evaluation. J Biol Chem 270:9896-9903
58. Kariv I, Stevens M, Behrens D, Oldenburg K (1999) High throughput quantitation of cAMP production mediated by activation of seven transmembrane domain receptors. J Biomol Screening 4:27-32
59. Prystay L, Gagne A, Kasila P, Yeh L, Banks P (2001) Homogeneous cell-based fluorescence polarization assay for the direct detection of cAMP. J Biomol Screening 6:75-82
60. Allen M, Hall D, Collins B, Moore K (2002) A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes. J Biomol Screening 7:35-44
61. Golla R, Seethala R (2002) A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. J Biomol Screening 7:515-525
62. Chiulli A, Trompeter K, Palmer M (2000) A novel high throughput chemiluminescent assay for the measurement of cellular cyclic adenosine monophosphate levels. J Biomol Screening 5:239-247
63. Selkirk J, Nottebaum L, Ford I, Santos M, Malany S, Foster A, Lechner S (2006) A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J Biomol Screening 11:351-358
64. Vrecl M, Jorgensen R, Pogacnik A, Heding A (2004) Development of a BRET2 screening assay using {beta}-Arrestin 2 mutants. J Biomol Screening 9:322-333
65. Ghosh R, DeBiasio R, Hudson C, Ramer E, Cowan C, Oakley R (2005) Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor(R)technology. J Biomol Screening 10:476-484
66. Hamdan F, Audet M, Garneau P, Pelletier J, Bouvier M (2005) High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based {beta}-Arrestin2 recruitment assay. J Biomol Screening 10:463-475
67. Shimomura O, Johnson F, Masugi T (1969) Cypridina bioluminescence: lightemitting oxyluciferin-luciferase complex. Science 164:1299, 1300
68. Terstappen G, Giacometti A, Ballini E, Aldegheri L (2000) Development of a functional reporter gene HTS assay for the identification of mGluR7 modulators. J Biomol Screening 5:255-261
69. Nieuwenhuijsen B, Huang Y, Wang Y, Ramirez F, Kalgaonkar G, Young K (2003) A dual luciferase multiplexed high-throughput screening platform for protein-protein interactions. J Biomol Screening 8:676-684
70. Kolb A, Neumann K (1996) Luciferase measurements in high throughput screening. J Biomol Screening 1:85-88
71. George S, Bungay P, Naylor L (1997) Evaluation of a CRE-directed luciferase reporter gene assay as an alternative to measuring cAMP accumulation. J Biomol Screening 2:235-240
72. Giuliano K, DeBiasio R, Dunlay T, Gough A, Volosky J, Zock J, Pavlakis G, Taylor DL (1997) High-content screening: a new approach to easing key bottlenecks in the drug discovery process. J Biomol Screening 6:249-259
73. Kamholz AE, Weigl BH, Finlayson BA, Yager P (1999) Quantitative analysis of molecular interaction in a microfluidic channel: the T-sensor. Anal Chem 71:5340-5347
74. Macounova K, Cabrera CR, Holl MR, Yager P (2000) Generation of natural pH gradients in microfluidic channels for use in isoelectric focusing. Anal Chem 72:3745-3751
75. Hadd AG, Raymond DE, Halliwell JW, Jacobson SC, Ramsey JM (1997) Microchip device for performing enzyme assays. Anal Chem 69:3407-3412
76. Duffy DC, Gillis HL, Lin J, Sheppard NF, Kellogg GJ (1999) Microfabricated centrifugal microfluidic systems: characterization and multiple enzymatic assays. Anal Chem 71:4669-4678
77. Hadd AC, Jacobson SC, Ramsey JM (1999) Microfluidic assays of acetylcholinesterase inhibitors. Anal Chem 71:5206-5212
78. Macounova K, Cabrera CR, Yager P (2001) Concentration and separation of proteins in microfluidic channels on the basis of transverse IEF. Anal Chem 73:1627-1633
79. Eteshola E, Leckband D (2001) Development and characterization of an ELISA assay in PDMS microfluidic channels. Sensors and Actuators B-Chemical 72:129-133
80. Yang TL, Jung SY, Mao HB, Cremer PS (2001) Fabrication of phospholipid bilayer-coated microchannels for on-chip immunoassays. Anal Chem 73: 165-169
81. Perrin D, Fremaux C, Besson D, Sauer W, Scheer A (2006) A microfluidics-based mobility shift assay to discover new tyrosine phosphatase inhibitors J Biomol Screening 11:108-112
82. Sohn LL (2000) Capacitance cytometry: measuring biological cells one by one. Proc Natl Acad Sci USA 97:10687-10690
83. Young S, Curry M, Ransom J, Ballesteros J, Prossnitz E, Sklar L, Edwards B (2004) High-throughput microfluidic mixing and multiparametric cell sorting for bioactive compound screening. J Biomol Screening 9:103-111
84. Gunter B, Brideau C, Pikounis Y, Liaw A (2003) Statistical and graphical methods for quality control determination of high-throughput screening data. J Biomol Screening 8:624-633
85. Gribbon P, Lyons R, Laflin P, Bradley J, Chambers C, Williams B, Keighley W, Sewing A (2005) Evaluating real-life high-throughput screening data. J Biomol Screening 10:99-107
86. Woodward P, Williams C, Sewing A, Benson N (2006) Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling. J Biomol Screening 11:5-12
87. Gunter B, Brideau C, Pikounis B, Liaw A (2003) Statistical and graphical methods for quality control determination of high-throughput screening data. J Biomol Screening 12: 8:624-633
88. Altekar M, Homon CA, Kashem MA, Mason SW, Nelson RM, Patnaude LA, Yingling J, Taylor PB (2006) Assay optimization: a statistical design of experiments approach. J Assoc Lab Automation 11:33-41
89. Sherrill T, Snider J, Terpstra N, Vanderpool C, Schmidt W (1999) Accelerating assay development using experimental design and integrated liquid handling. J Assoc Lab Automation 4:76-84
90. Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screening 4:67-73
91. Balaban AT (1979) Five new topological indices for the branching of tree-like graphs. Theoretica Chimica Acta 53:355-375
92. Balaban AT (1982) Highly discriminating distance-based topological index. Chem Phys Lett 89:399-404, CRC Handbook of Chemistry and Physics (1994). CRC, Boca Ratan, FL
93. CRC Handbook of Chemistry and Physics (1994). CRC, Boca Ratan, FL 94. Wildman SA, Crippen GM (1999) Prediction of physiochemical parameters by atomic contributions. J Chem Inf Comput Sci 39:868-873
94. Gasteiger J, Marsali M (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36:3219
95. Hall LH, Kier LB (1991) The molecular connectivity chi indices and kappa shape indices in structure-property modeling. Rev Computational Chem 2:367-422
96. Hall LH, Kier LB (1997) The nature of structure-Activity relationships and their relation to molecular connectivity. Eur J Med Chem Chimica Therapeutica 4:307-312
97. Petitjean M (1992) Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J Chem Inf Comput Sci 32:331-337
98. Wiener H (1947) Structural determination of paraffin boiling points. J Am Chem Soc 69:17-20
99. Soderholm J, Uehara-Bingen M, Weis K, Heald R (2006) Challenges facing the biologist doing chemical genetics. Nat Chem Biol 2:55-58
100. Provis J (2005) Compound management and enhancement activities in astrazeneca. J Assoc Lab Automation 10:124-129
101. Moore KW, Chandler G, Whalley P, Gannon D, Simpson PB (2006) Efficient sample logistics: from the chemist to the assay plate and beyond. J Assoc Lab Automation 11:92-99
102. Brideau C, Hunter J, Maher J, Adam S, Fortin LJ, Ferentinos J (2004) SOS - a sample ordering system for delivering assay-ready compound plates for drug screening. J Assoc Lab Automation 9:123-127
103. Solomon FJ, DeChard CS, Donnenberg R (2006) The design, development, and implementation of a fully automated compound distribution center. J Assoc Lab Automation 11:138-144
104. Gedrych M (2000) Automated compound storage and retrieval system for microplates and tubes. J Assoc Lab Automation 5:24-25
105. Schopfer U (2005) The novartis compound archive: from concept to reality. Comb Chem High Throughput Screen 8:213
106. Beggs M, Blok H, Mertens J (1999) Stacker modules used in a high-capacity robotics system for high throughput screening compound replication. J Biomol Screening 4:373-379
107. Harrison W (1997) The importance of automated sample management systems in realizing the potential of large compound libraries in drug discovery. J Biomol Screening 2:203-206
108. Cheng X, Hochlowski J, Tang H, Hepp D, Beckner C, Kantor S, Schmitt R (2003) Studies on repository compound stability in dmso under various conditions. J Biomol Screening 8:292-304
109. Tjernberg A, Markova N, Griffiths W, Hallen D (2006) DMSO-related effects in protein characterization. J Biomol Screening 11:131-137
110. Kozikowski B, Burt T, Tirey D, Williams L, Kuzmak B, Stanton D, Morand K, Nelson S (2003) The effect of freeze/thaw cycles on the stability of compounds in DMSO. J Biomol Screening 8:210-215
111. Kozikowski B, Burt T, Tirey D, Williams L, Kuzmak B, Stanton D, Morand K, Nelson S (2003) The effect of room-temperature storage on the stability of compounds in DMSO. J Biomol Screening 8:205-209
112. Semin D, Malone T, Paley M, Woods P (2005) A novel approach to determine water content in DMSO for a compound collection repository. J Biomol Screening 10:568-572
113. Balakin K, Ivanenkov Y, Skorenko A, Nikolsky Y, Savchuk N, Ivashchenko A (2004) In silico estimation of dmso solubility of organic compounds for bioscreening. J Biomol Screening 9:22-31
114. Rasmussen D, Mackenzie A (1969) Phase diagram for the system water -dimethylsulphoxide. Nature 220:1315-1317
115. Menke K (2002) Unit automation in high throughput screening, In: Janzen W. (ed)) High throughput screening methods and protocols. Humana, Totowa, NJ, pp 195-212
116. Cohen S, Trinka R (2002) Fully automated screening systems. In: Janzen W (ed)) High throughput screening methods and protocols. Humana, Totowa, NJ, pp 213-228
117. Hodder P, Mull R, Cassaday J, Berry K, Strulovici B (2004) Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader. J Biomol Screening 9:417-426
118. George J, Teear ML, Norey CG, Burns DD (2003) Evaluation of an imaging platform during the development of a fret protease assay. J Biomol Screening 8:72-80
119. Sorg G, Schubert H, Buttner FH, Heilker R (2002) Automated high throughput screening for serine kinase inhibitors using a LEADSeekerTM scintillation proximity assay in the 1536-well format. J Biomol Screening 7:11-19
120. Ramm P, Alexandrov Y, Cholewinski A, Cybuch Y, Nadon R, Soltys B (2003) Automated screening of neurite outgrowth. J Biomol Screening 8:7-18
121. Skwish S, Asensio F, Gregking Clarke G, Kath G, Salvatore MJ, Dufresne C (2004) FIZICS: fluorescent imaging zone identification system, a novel macro imaging system. J Biomol Screening 9:663-370
122. Popa-Burke IG, Issakova O, Arroway JD, Bernasconi P, Chen M, Coudurier L, Galasinski S, Janzen WP, Lagasca D, Liu D, Lewis RS, Mohney RP, Sepetov N, Sparkman DA, Hodge CN (2004) Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results. Analytical Chemistry 76:7278-7287
123. Jager S, Garbow N, Kirsch A, Preckel H, Gandenberger FU, Herrenknecht K, Rudiger M, Hutchinson JP, Bingham RP, Ramon F, Bardera A, Martin J (2003) A modular, fully integrated ultra-high-throughput screening system based on confocal fluorescence analysis techniques. J Biomol Screening 8:648-659
124. Fogel P, Collette P, Dupront A, Garyantes T, Guedini D (2002) The confirmation rate of primary hits: a predictive model. J Biomol Screening 7:175-190
125. Hubert CL, Sherling SE, Johnston PA, Stancato LF (2003) Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J Biomol Screening 8:399-409
126. Janzen WP, Hodge CN (2006) A chemogenonic approach to discovering target selective drugs. Chem Biol Drug Design 67:85-86
127. Kaiser J (2004) NIH gears up for chemical genomics. Science 304:1728
128. http://mli.nih.gov/index.php